Canada Joins the US and UK in Controversial Clinical Trails Using MDMA
People suffer trauma every day. Car accidents happen, violence is rampant, and our troops overseas deal with more than is necessary. While some people are able to deal with and walk away from traumatic experiences, not all of us have that luxury. Those with high anxiety and Post Traumatic Stress Disorder (PTSD) can now get a glimpse of the light at the end of the tunnel. The US, UK, and now Canada have gotten the ball rolling on an innovative and controversial treatment for these ailments. Kandi Kidz rejoice, for Methylenedioxymethamphetamine (MDMA, the main drug in Ecstasy) is the answer.
Just as the US starts Phase 2 of clinical trials using MDMA, Canada has joined in on the idea. Importing the drug from Switzerland, where its manufacturing has been approved and highly regulated, Canadian researchers are patiently waiting the drug’s arrival for clinical trials. Even though nothing has been received quite yet, word has gotten out, and more than a handful of people are eagerly waiting to “test” out the drug.
Before you go thinking that these researchers have gone off their rocker, they are actually gaining a less biased and more realistic view of MDMA. The drug has the uncanny ability to allow people to truly take in the information presented to them, while still altering their emotional state. The alteration, however, is of pure euphoria and understanding. Those who suffer from severe anxiety and PTSD cannot reach a certain point in their therapy, because their adrenaline responses go into overdrive. Panic sets in and the response can be devastating, resulting in panic attacks, anxiety attacks, and even outward violence. When these patients are under the influence of MDMA (in a controlled setting), they can relive their trauma and outwardly speak about it without going into a panic. It’s as though the trauma never bothered them. Don’t get me wrong, one therapy session cannot fix or cure PTSD, but with regulated trials and comfortable therapy sessions, the impact of these traumas can be greatly dampened. MDMA allows doctor and patient to bring everything to the table with comfort. That can’t be all bad, right?
No one has approved MDMA for prescription use, and it won’t even be considered for approval in the US until at least 2021. With that being said, the fact that clinical trials have been considered, approved, and started is a jump in the right direction.